Varicella-zoster virus causes chickenpox and is a member of the herpes virus group. It is extremely contagious and causes a ...

SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with ...

By Keith Roach, M.D. TITLE: 63-year-old debates getting shingles and chicken pox vaccines---DEAR DR. ROACH: A few months ago, yo ...

Cohen's research is waiting for peer review and publication. There is a vaccine for shingles that's more than 90% effective but only about a quarter of eligible adults get it. "I'm hoping that we ...

Finally, it’s too late for your mother, but older people who have not had the newer two-dose shingles vaccine (Shingrix) ...

Adults should discuss with their doctors about whether this vaccine is necessary. It is recommended that adults 50 and older receive two doses of Shingrix, the shingles vaccine, two to six months ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

“I’m optimistic and believe Shingrix will also be effective at reducing shingles and its sequelae, especially with how effective the vaccine has shown to be in other settings,” said Harris. Harris ...

The current $4+ billion shingles vaccine market is characterized by accessibility issues and vaccine hesitancy/dose avoidance related to vaccine tolerability. Curevo is also developing a non-live, non ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit ...

The current $4+ billion shingles vaccine market is characterized by accessibility issues and vaccine hesitancy/dose avoidance related to vaccine tolerability. Curevo is also developing a non-live ...